Takeover offer

001. Rule 2.7 Announcement - 18 November 2019

002. Nasdaq Press Release (English) - 18 November 2019

003. Nasdaq Press Release (Swedish) - 18 November 2019

004. Investor Presentation - 18 November 2019

005. Lazard Consent Letter - 18 November 2019

006. Evercore Consent Letter - 18 November 2019

007. Irrevocable Undertaking (Chris Brinsmead) - 18 November 2019

008. Irrevocable Undertaking (Charlotta Ginman) - 18 November 2019

009. Irrevocable Undertaking (Jonathan Glenn) - 18 November 2019

010. Irrevocable Undertaking (Paul Hayes) - 18 November 2019

011. Irrevocable Undertaking (Andrew Hosty) - 18 November 2019

012. Irrevocable Undertaking (William Jenkins) - 18 November 2019

013. Irrevocable Undertaking (Ian Nicholson) - 18 November 2019

014. Confidentiality Agreement - 25 October 2019

015. Co-operation Agreement - 18 November 2019

016. Facilities Agreement - 18 November 2019

017. Interim Facilities Agreement - 18 November 2019

018. Syndication Letter - 18 November 2019

019. Fee Letter - 18 November 2019

020. Agency Fee Letter - 18 November 2019

021. Larger institutional shareholders support Recipharm’s cash offer for Consort Medical and subsequent rights issue

022. Offer Document - 6 December 2019

023. Announcement of Publication of Offer Document - 6 December 2019

024. Sample Form of Acceptance

025. Articles of Association of Recipharm Holdings Limited

026. Articles of Association of Recipharm AB

027. Articles of Association of Consort Medical plc

028. Lazard Consent Letter - 6 December 2019

029. Evercore Consent Letter - 6 December 2019

030. Investec Consent Letter - 6 December 2019

031. Peel Hunt Consent Letter - 6 December 2019

032. Global Transfer Agreement – 18 December 2019

033. Nasdaq Press Release (English) - 06 December 2019

034. Nasdaq Press Release (Swedish) - 06 December 2019

035. Announcement of Offer Extension and Acceptance Level Update - 10 January 2020

036. Nasdaq Press Release (English) - 10 January 2020

037. Nasdaq Press Release (Swedish) - 10 January 2020

038. DBP Rule 15 Letter

039. DBP Form of Instruction

040. PSP Rule 15 Letter

041. PSP Form of Instruction

042. UK Sharesave Rule 15 Letter

043. UK Sharesave Form of Instruction

044. UK Sharesave Form of Instruction Terms and Conditions

045. Nasdaq Press Release (English) - 14 January 2020

046. Nasdaq Press Release (Swedish) - 14 January 2020

047. Announcement of German Competition Clearance - 14 January 2020

048. SIP Letter - 17 January 2020

049. UK Form of Instruction - 17 January 2020

050. Nasdaq Press Release (English) - 22 January 2020

051. Nasdaq Press Release (Swedish) - 22 January 2020

052. Announcement of Acquisition of Shares - 22 January 2020

053. Nasdaq Press Release (English) - 24 January 2020

054. Nasdaq Press Release (Swedish) - 24 January 2020

055. Correction Statement  (English) - 24 January 2020

056. Correction Statement  (Swedish) - 24 January 2020

057. Announcement of Offer Extension and Acceptance Level Update - 24 January 2020

058. Correction Announcement re Acquisition of Shares - 24 January 2020

059. Nasdaq Press Release (English) - 29 January 2020

060. Nasdaq Press Release (Swedish) - 29 January 2020

061. Announcement of No extension or Increase  Irish CCPC Clearance

062. Nasdaq Press Release (English) - 4 February 2020

063. Nasdaq Press Release (Swedish) - 4 February 2020

064. Announcement of Offer being declared Wholly Unconditional - 4 February 2020

065. Nasdaq Press Release (English) - 5 February 2020

066. Nasdaq Press Release (Swedish) - 5 February 2020

067. Amendment Request Letter - 4 February 2020

068. Consent Letter - 4 February 2020

069. Nasdaq Press Release (English) - 6 February 2020

070. Nasdaq Press Release (Swedish) - 6 February 2020

071. Press Release (English) - 7 February 2020

072. Press Release (Swedish) - 7 February 2020

073. Announcement of Notice of Cancellation of Listing - 6 February 2020

074. Nasdaq Press Release (English) - 17 February 2020

075. Nasdaq Press Release (Swedish) - 17 February 2020

076. Announcement of 90 per cent. and commencement date of squeeze-out procedure - 17 February 2020

077. Press Release (English) - 20 February 2020

078. Press Release (Swedish) - 20 February 2020

079. Charlie - Announcement re Despatch of Squeeze-Out Notice

080. Press Release (English) - 6 March 2020

081. Press Release (Swedish) - 6 March 2020

082. Announcement of Delisting Completion – 6 March 2020

083. Charlie - Amendment Fee Letter (Redacted)

084. Lazard Consent Letter - 24 March 2020